0310-0625Level 3
KOSELUGO (SELUMETINIB)
**Product type:** Human Prescription Drug
**Active ingredient:** SELUMETINIB
**Strength:** 25 mg/1
**Dosage form:** Capsule
**Route:** Oral
**Labeler:** AstraZeneca Pharmaceuticals LP
**Marketing category:** NDA (NDA213756)
**Pharmacologic class:** Kinase Inhibitor [EPC], Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA], Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/0310-0625Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.